Daniel J. Marnell

Dermatology
6367 Alvarado Ct Ste 107
San Diego, CA 92120

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).

Journal: Journal of the American Academy of Dermatology
Published: August 18, 2020
Showing 1-1 of 1

Last Updated: 09/26/2026